Plenary programme

Monday 05 October

NATURE AND NURTURE - IMPACT OF TRADITIONAL RISK FACTORS, ENVIRONMENT AND GENES

Chair:
  • Lale Tokgözoglu
  • François Mach
Global perspectives of cardiovascular disease, and impact of risk factors
To be announced
Can polygenic scores reach clinical practice?
Anne Tybjærg-Hansen, Copenhagen, Denmark
What is the environment doing to cardiovascular health?
Nicole Probst-Hensch, Basel, Switzerland
Age, the unpreventable risk factor - targeting senescence
Jan van Deursen, Rochester, USA

Tuesday 06 October

UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION

Chair:
  • Alberico L. Catapano
  • Jan Boren
The lipoprotein(a) story - from risk factor to causality to clinical trials
Sotirios Tsimikas, La Jolla, USA
Immune modulation in atherosclerosis
Ziad Mallat, Cambridge, UK
Prevention of cardiovascular diseases by glucose lowering drugs
Stefano del Prato, Pisa, Italy
Taming the gut microbiota
Stanley Hazen, Cleveland, USA
Will non-coding RNAs change our understanding of vascular biology and disease?
Stephanie Dimmeler, Frankfurt, Germany

Wednesday 07 October

THE CHANGING LANDSCAPE IN ATHEROSCLEROTIC VASCULAR DISEASE - BRAVE NEW WORLD

Chair:
  • Arnold von Eckardstein
  • Ruth Frikke-Schmidt
Implementing systems biology to personalise medicine
Johan Björkegren, Stockholm, Sweden
AI in CVD & beyond
Jörg Menche, Vienna, Austria
Personalised medicine in the elderly – how to avoid overtreatment
Heike Bischoff-Ferrari, Zurich, Switzerland
New therapeutic approaches
John J.P. Kastelein, Amsterdam, The Netherlands